Central Garden & Pet Company (CENT)
CENT Strengthens Animal Health Portfolio With Champion USA Acquisition
Central Garden & Pet expands animal health, acquiring Champion USA's U.S. assets and JustiFLY to boost livestock presence.
Why Central Garden (CENT) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Central Garden & Pet: Margin Strength Intact Despite Soft Demand
CENT demonstrates operational excellence, with FY25 marking a pivotal margin expansion and a resilient operating base. It's multi-year Cost & Simplicity program, portfolio reshaping, and facility consolidation have structurally improved margins, outpacing industry peers. Despite weak consumer confidence and $20M in incremental tariffs, CENT maintains disciplined cost controls and targets continued profit expansion in FY26.
Central Garden & Pet Posts Narrower-Than-Expected Q4 Loss, Sales Rise
CENT posts a narrower Q4 loss as sales rise, gross margin expands and Garden strength offsets pressure in pet durables.
Central Garden (CENT) Reports Q4 Loss, Beats Revenue Estimates
Central Garden (CENT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.18 per share a year ago.
Central Garden (CENT) Expected to Beat Earnings Estimates: Should You Buy?
Central Garden (CENT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Central Garden (CENT) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Central Garden (CENT) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Central Garden (CENT) is Poised to Beat Earnings Estimates Again
Central Garden (CENT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Central Garden (CENT) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Central Garden And Pet Traded Growth For Major Margin Gains
Central Garden and Pet (CENT) is rated a strong buy despite recent stock declines and negative revenue growth, due to margin improvements and acquisition potential. CENT's Cost and Simplicity program drives higher margins by exiting low-profit markets and focusing on consumables, even as short-term sales decline. Management may expect continued negative organic growth but plans to pursue acquisitions in 2026, possibly targeting premium consumables for higher-margin, repeat business.
4 Consumer Discretionary Stocks to Watch This Holiday Season
Interparfums, Central Garden & Pet Company, RealReal and Honest Company focus on a superior product strategy and prudent capital investments.
